应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARQT Arcutis Biotherapeutics Inc.
休市中 05-02 16:00:00 EDT
15.24
+0.59
+4.03%
盘后
15.30
+0.06
+0.39%
19:58 EDT
最高
15.58
最低
14.74
成交量
156.60万
今开
14.75
昨收
14.65
日振幅
5.73%
总市值
18.08亿
流通市值
12.99亿
总股本
1.19亿
成交额
2,379万
换手率
1.84%
流通股本
8,524万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Arcutis Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.05%
市场透视 · 05-02 15:24
Arcutis Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.05%
Arcutis Biotherapeutics, Inc.盘中异动 股价大跌5.23%
市场透视 · 05-01 13:52
Arcutis Biotherapeutics, Inc.盘中异动 股价大跌5.23%
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.42%
市场透视 · 04-23
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.42%
Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大涨5.00%
市场透视 · 04-21
Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大涨5.00%
Arcutis Biotherapeutics, Inc.盘中异动 早盘快速上涨5.32%
市场透视 · 04-17
Arcutis Biotherapeutics, Inc.盘中异动 早盘快速上涨5.32%
Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 04-16
Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大跌5.00%
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.02%
市场透视 · 04-15
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.02%
Arcutis Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.00%报13.22美元
市场透视 · 04-14
Arcutis Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.00%报13.22美元
Arcutis Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.22%报13.50美元
市场透视 · 03-04
Arcutis Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.22%报13.50美元
Arcutis Biotherapeutics, Inc.盘中异动 大幅下跌5.04%报13.00美元
市场透视 · 03-03
Arcutis Biotherapeutics, Inc.盘中异动 大幅下跌5.04%报13.00美元
Arcutis Biotherapeutics, Inc.2024财年实现净利润-1.40亿美元,同比增加46.56%
市场透视 · 03-01
Arcutis Biotherapeutics, Inc.2024财年实现净利润-1.40亿美元,同比增加46.56%
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.08%报13.45美元
市场透视 · 02-28
Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.08%报13.45美元
高盛:维持Arcutis Biotherapeutics(ARQT.US)评级,由中性调整至中性评级, 目标价由13.00美元调整至15.00美元。
金融界 · 02-27
高盛:维持Arcutis Biotherapeutics(ARQT.US)评级,由中性调整至中性评级, 目标价由13.00美元调整至15.00美元。
瑞穗银行:维持Arcutis Biotherapeutics(ARQT.US)评级,由优于大市调整至优于大市评级, 目标价由20.00美元调整至21.00美元。
金融界 · 02-26
瑞穗银行:维持Arcutis Biotherapeutics(ARQT.US)评级,由优于大市调整至优于大市评级, 目标价由20.00美元调整至21.00美元。
Arcutis Biotherapeutics, Inc.股价上涨10.20% 市值涨1.63亿美元
市场透视 · 02-26
Arcutis Biotherapeutics, Inc.股价上涨10.20% 市值涨1.63亿美元
异动解读 | 亿万销售创新高,Arcutis Biotherapeutics盘前大涨9.18%
异动解读 · 02-26
异动解读 | 亿万销售创新高,Arcutis Biotherapeutics盘前大涨9.18%
异动解读 | Arcutis Biotherapeutics公司去年第四季度业绩大增,股价盘后大涨9.02%
异动解读 · 02-26
异动解读 | Arcutis Biotherapeutics公司去年第四季度业绩大增,股价盘后大涨9.02%
异动解读 | Arcutis Biotherapeutics盘后大涨8.36%,2024年Q4财报亮眼
异动解读 · 02-25
异动解读 | Arcutis Biotherapeutics盘后大涨8.36%,2024年Q4财报亮眼
Arcutis Biotherapeutics 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.24),销售额$71.400M优于预期$60.160M
财报速递 · 02-25
Arcutis Biotherapeutics 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.24),销售额$71.400M优于预期$60.160M
Arcutis Biotherapeutics, Inc.盘中异动 临近午盘股价大跌5.00%报11.77美元
市场透视 · 02-25
Arcutis Biotherapeutics, Inc.盘中异动 临近午盘股价大跌5.00%报11.77美元
加载更多
公司概况
公司名称:
Arcutis Biotherapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arcutis Biotherapeutics, Inc.前身是根据特拉华州法律于2016年6月成立的,名称为Arcutis,Inc.,后将名称更改为Arcutis Biotherapeutics,Inc.。该公司是一家后期生物制药公司,致力于针对医疗需求未得到满足的皮肤病开发和商业化治疗。该公司目前的产品组合包括局部治疗,具有潜在的潜力,可以解决免疫介导的皮肤病和疾病或免疫皮肤病。该公司的策略是针对皮肤病学中经过验证的生物学目标识别和开发治疗方法,以提供差异化的临床特征,从而解决现有疗法在目标适应症方面的主要缺点。
发行价格:
--
{"stockData":{"symbol":"ARQT","market":"US","secType":"STK","nameCN":"Arcutis Biotherapeutics Inc.","latestPrice":15.24,"timestamp":1746216000000,"preClose":14.65,"halted":0,"volume":1565963,"hourTrading":{"tag":"盘后","latestPrice":15.3,"preClose":15.24,"latestTime":"19:58 EDT","volume":17264,"amount":263233.4641,"timestamp":1746230332158},"delay":0,"floatShares":85242342,"shares":118638235,"eps":-1.157752,"marketStatus":"休市中","change":0.59,"latestTime":"05-02 16:00:00 EDT","open":14.75,"high":15.58,"low":14.74,"amount":23793940.241497997,"amplitude":0.057338,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.157752,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1580446800000,"exchange":"NASDAQ","adjPreClose":14.65,"preHourTrading":{"tag":"盘前","latestPrice":14.74,"preClose":14.65,"latestTime":"09:29 EDT","volume":3066,"amount":45363.760302,"timestamp":1746192599999},"postHourTrading":{"tag":"盘后","latestPrice":15.3,"preClose":15.24,"latestTime":"19:58 EDT","volume":17264,"amount":263233.4641,"timestamp":1746230332158},"volumeRatio":1.2606865027282734,"impliedVol":0.8896,"impliedVolPercentile":0.552},"requestUrl":"/m/hq/s/ARQT","defaultTab":"news","newsList":[{"id":"2532682523","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532682523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532682523?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:24","pubTimestamp":1746199463,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时24分,Arcutis Biotherapeutics, Inc.股票出现波动,股价快速上涨5.05%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,Polyrizon Ltd.、Impact Biomedical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Impact Biomedical, Inc.、Pmgc Holdings Inc.、Polyrizon Ltd.较为活跃,换手率分别为877.85%、649.83%、541.71%,振幅较大的相关个股有Polyrizon Ltd.、Impact Biomedical, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为267.88%、112.75%、71.36%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050223242394ead170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050223242394ead170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBO","ARQT","BK4139","BK4007"],"gpt_icon":0},{"id":"2532037450","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532037450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532037450?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:52","pubTimestamp":1746107545,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时52分,Arcutis Biotherapeutics, Inc.股票出现波动,股价大幅下挫5.23%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.42%。其相关个股中,Transcode Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为94.34%、35.37%、16.65%,振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.,振幅分别为36.89%、24.75%、18.78%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215225974c99d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215225974c99d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2529680988","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529680988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529680988?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:34","pubTimestamp":1745415240,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时34分,Arcutis Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.42%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.55%。其相关个股中,Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃,换手率分别为3200.84%、18.95%、9.94%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Seres Therapeutics, Inc.,振幅分别为41.18%、29.61%、16.91%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213401974232c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213401974232c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2529980002","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529980002?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:21","pubTimestamp":1745245271,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时21分,Arcutis Biotherapeutics, Inc.股票出现波动,股价急速拉升5.00%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为1008.16%、700.30%、325.48%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为106.34%、58.81%、43.24%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222111a6c27d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421222111a6c27d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2528438477","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘快速上涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528438477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528438477?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:38","pubTimestamp":1744897111,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时38分,Arcutis Biotherapeutics, Inc.股票出现波动,股价大幅拉升5.32%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大,Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为399.28%、144.18%、45.38%,振幅较大的相关个股有Channel Therapeutics Corporation、Sol-Gel Technologies Ltd.、Portage Biotech Inc.,振幅分别为35.06%、15.63%、14.67%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213831973b5328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213831973b5328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2527810249","title":"Arcutis Biotherapeutics, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527810249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527810249?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:00","pubTimestamp":1744812002,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日22时00分,Arcutis Biotherapeutics, Inc.股票出现波动,股价快速下挫5.00%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.46%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Dermata Therapeutics Inc C/Wts 、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为458.01%、152.71%、77.30%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Mei Pharma, Inc.、Quoin Pharmaceuticals Ltd,振幅分别为50.48%、29.90%、29.30%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220002a6bca9da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416220002a6bca9da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2527452234","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527452234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527452234?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:42","pubTimestamp":1744728122,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时42分,Arcutis Biotherapeutics, Inc.股票出现波动,股价快速拉升5.02%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Mural Oncology Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Skye Bioscience, Inc.涨幅较大,Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃,换手率分别为905.45%、232.41%、96.64%,振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为171.53%、86.41%、80.08%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415224202a6bb5d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415224202a6bb5d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2527127621","title":"Arcutis Biotherapeutics, Inc.盘中异动 下午盘股价大涨5.00%报13.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527127621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527127621?lang=zh_cn&edition=full","pubTime":"2025-04-15 02:24","pubTimestamp":1744655089,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日02时24分,Arcutis Biotherapeutics, Inc.股票出现异动,股价快速上涨5.00%。截至发稿,该股报13.22美元/股,成交量107.005万股,换手率0.90%,振幅4.37%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.42%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Third Harmonic Bio, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为799.19%、680.48%、336.10%,振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为78.58%、66.92%、45.11%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415022449a6ba5200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415022449a6ba5200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2517524988","title":"Arcutis Biotherapeutics, Inc.盘中异动 下午盘急速拉升5.22%报13.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517524988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517524988?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:56","pubTimestamp":1741114573,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时56分,Arcutis Biotherapeutics, Inc.股票出现波动,股价快速上涨5.22%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大,Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃,换手率分别为1293.93%、1186.20%、1169.09%,振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为122.48%、68.89%、66.02%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502561396398385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030502561396398385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2516630861","title":"Arcutis Biotherapeutics, Inc.盘中异动 大幅下跌5.04%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630861?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:08","pubTimestamp":1741014524,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时08分,Arcutis Biotherapeutics, Inc.股票出现波动,股价大幅下挫5.04%。截至发稿,该股报13.00美元/股,成交量42.1476万股,换手率0.36%,振幅6.28%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1220.90%、127.04%、104.27%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.,振幅分别为163.15%、70.53%、48.34%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230844989a1a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230844989a1a89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT","BK4139"],"gpt_icon":0},{"id":"2516312557","title":"Arcutis Biotherapeutics, Inc.2024财年实现净利润-1.40亿美元,同比增加46.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516312557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516312557?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844864,"startTime":"0","endTime":"0","summary":"3月2日,Arcutis Biotherapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.40亿美元,同比增加46.56%;其中营业收入为1.97亿美元,同比增加230.48%,每股基本收益为-1.16美元。从资产负债表来看,Arcutis Biotherapeutics, Inc.总负债1.91亿美元,其中短期债务820000.00美元,资产负债比为1.83,流动比率为0.05。机构评级:截至2025年3月2日,当前有7家机构对Arcutis Biotherapeutics, Inc.目标价做出预测,其中目标均价为20.00美元,其中最低目标价为15.00美元,最高目标价为29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000132abe2c5b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000132abe2c5b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARQT"],"gpt_icon":0},{"id":"2516301367","title":"Arcutis Biotherapeutics, Inc.盘中异动 股价大涨5.08%报13.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301367?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:46","pubTimestamp":1740775606,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时46分,Arcutis Biotherapeutics, Inc.股票出现异动,股价快速拉升5.08%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.75%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Camp4 Therapeutics Corporation、Enveric Biosciences, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为3285.97%、607.09%、401.71%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ,振幅分别为57.80%、49.90%、48.19%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010446469896c6aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010446469896c6aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"2514333380","title":"高盛:维持Arcutis Biotherapeutics(ARQT.US)评级,由中性调整至中性评级, 目标价由13.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514333380","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514333380?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674501,"startTime":"0","endTime":"0","summary":"高盛:维持Arcutis Biotherapeutics(ARQT.US)评级,由中性调整至中性评级, 目标价由13.00美元调整至15.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28004148440835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARQT"],"gpt_icon":0},{"id":"2514857342","title":"瑞穗银行:维持Arcutis Biotherapeutics(ARQT.US)评级,由优于大市调整至优于大市评级, 目标价由20.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857342","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514857342?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:11","pubTimestamp":1740586273,"startTime":"0","endTime":"0","summary":"瑞穗银行:维持Arcutis Biotherapeutics(ARQT.US)评级,由优于大市调整至优于大市评级, 目标价由20.00美元调整至21.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27001148413685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["161121","ARQT"],"gpt_icon":0},{"id":"2514856805","title":"Arcutis Biotherapeutics, Inc.股价上涨10.20% 市值涨1.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856805?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:32","pubTimestamp":1740580329,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时32分,Arcutis Biotherapeutics, Inc.股票出现异动,股价快速拉升10.20%。截至发稿,该股报13.45美元/股,成交量13.6755万股,换手率0.12%,振幅6.56%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Enveric Biosciences, Inc.、Nutriband Inc C/Wts 、Channel Therapeutics Corporation涨幅较大,Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为2782.30%、115.75%、90.27%,振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.,振幅分别为28.81%、16.85%、14.35%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223209a254f693&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223209a254f693&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0},{"id":"1156921339","title":"异动解读 | 亿万销售创新高,Arcutis Biotherapeutics盘前大涨9.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156921339","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156921339?lang=zh_cn&edition=full","pubTime":"2025-02-26 18:48","pubTimestamp":1740566920,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics Inc.于今日盘前大涨9.18%,引发市场广泛关注。此前,该公司发布了2024年第四季度财报,数据显示其销售额达到7140万美元,同比大涨427.87%,远超市场普遍预期。与销售业绩一致,Arcutis第四季度每股亏损仅为0.09美元,远低于分析师预期的0.24美元亏损。出色的业绩数据令投资者对公司未来发展充满信心,推动盘前股价大幅飙升。作为一家专注皮肤疾病创新治疗的生物科技公司,Arcutis近期的表现无疑为其在行业内赢得一席之地,并吸引更多投资者关注。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARQT"],"gpt_icon":0},{"id":"1154950948","title":"异动解读 | Arcutis Biotherapeutics公司去年第四季度业绩大增,股价盘后大涨9.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154950948","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154950948?lang=zh_cn&edition=full","pubTime":"2025-02-26 09:17","pubTimestamp":1740532644,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics公司于盘后大涨9.02%,引起了市场广泛关注。财报显示,Arcutis去年第四季度每股亏损仅为0.09美元,而分析师此前预期为0.24美元。较上年同期亏损0.72美元,亏损幅度大幅收窄。值得注意的是,公司2024年第四季度销售额达到7140万美元,较上年同期增长427.87%,远超市场普遍预期的6016万美元。作为一家专注于开发创新药物治疗皮肤疾病的生物技术公司,Arcutis Biotherapeutics出色的销售数据证明了其产品在市场上备受青睐,未来发展潜力值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARQT"],"gpt_icon":0},{"id":"1110411586","title":"异动解读 | Arcutis Biotherapeutics盘后大涨8.36%,2024年Q4财报亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1110411586","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110411586?lang=zh_cn&edition=full","pubTime":"2025-02-26 05:33","pubTimestamp":1740519237,"startTime":"0","endTime":"0","summary":"生物技术公司Arcutis Biotherapeutics昨日盘后大涨8.36%,引发市场关注。公司于当日公布了2024年第四季度财报,业绩表现出色或是导致股价上涨的主要原因。财报显示,Arcutis Biotherapeutics去年第四季度每股亏损仅为0.09美元,优于分析师平均预期亏损0.24美元。与去年同期相比,亏损幅度显著收窄。作为一家专注于发现、开发和商业化治疗皮肤病学疾病的创新药物的公司,Arcutis Biotherapeutics的业绩表现令市场投资者重拾信心。若公司能够持续保持良好的销售增长势头,股价有望进一步走高。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Arcutis Biotherapeutics盘后大涨8.36%,2024年Q4财报亮眼","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARQT"],"gpt_icon":0},{"id":"1177629478","title":"Arcutis Biotherapeutics 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.24),销售额$71.400M优于预期$60.160M","url":"https://stock-news.laohu8.com/highlight/detail?id=1177629478","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177629478?lang=zh_cn&edition=full","pubTime":"2025-02-26 05:04","pubTimestamp":1740517464,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics报告季度每股亏损$,比分析师普遍预期的$高62.5%。与去年同期每股亏损$相比,这一数据增加了87.5%。公司报告季度销售额为$71.400百万,超出分析师普遍预期的$60.160百万,增幅为18.68%。以上内容来自Benzinga Earnings专栏,原文如下:Arcutis Biotherapeutics reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 62.5 percent. This is a 87.5 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $71.400 million which beat the analyst consensus estimate of $60.160 million by 1","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Arcutis Biotherapeutics 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.24),销售额$71.400M优于预期$60.160M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT"],"gpt_icon":0},{"id":"2514301414","title":"Arcutis Biotherapeutics, Inc.盘中异动 临近午盘股价大跌5.00%报11.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514301414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514301414?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:46","pubTimestamp":1740502010,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时46分,Arcutis Biotherapeutics, Inc.股票出现波动,股价快速下跌5.00%。截至发稿,该股报11.77美元/股,成交量76.5804万股,换手率0.65%,振幅6.38%。Arcutis Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Gt Biopharma, Inc.、Silexion Therapeutics Corp、Moleculin Biotech, Inc.较为活跃,换手率分别为1120.96%、935.06%、699.51%,振幅较大的相关个股有Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Adial Pharmaceuticals, Inc,振幅分别为87.83%、66.67%、64.05%。Arcutis Biotherapeutics, Inc.公司简介:Arcutis Biotherapeutics Inc 是一家医学皮肤科公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260046519892687d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260046519892687d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARQT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcutis.com","stockEarnings":[{"period":"1week","weight":0.0431},{"period":"1month","weight":-0.0819},{"period":"3month","weight":0.1511},{"period":"6month","weight":0.7578},{"period":"1year","weight":0.7721},{"period":"ytd","weight":0.094}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcutis Biotherapeutics, Inc.前身是根据特拉华州法律于2016年6月成立的,名称为Arcutis,Inc.,后将名称更改为Arcutis Biotherapeutics,Inc.。该公司是一家后期生物制药公司,致力于针对医疗需求未得到满足的皮肤病开发和商业化治疗。该公司目前的产品组合包括局部治疗,具有潜在的潜力,可以解决免疫介导的皮肤病和疾病或免疫皮肤病。该公司的策略是针对皮肤病学中经过验证的生物学目标识别和开发治疗方法,以提供差异化的临床特征,从而解决现有疗法在目标适应症方面的主要缺点。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.117216},{"month":2,"riseRate":0.833333,"avgChangeRate":0.23515},{"month":3,"riseRate":0.5,"avgChangeRate":-0.027279},{"month":4,"riseRate":0.5,"avgChangeRate":0.042439},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.080136},{"month":6,"riseRate":0.8,"avgChangeRate":0.067805},{"month":7,"riseRate":0.6,"avgChangeRate":0.020773},{"month":8,"riseRate":0.4,"avgChangeRate":-0.035909},{"month":9,"riseRate":0.4,"avgChangeRate":-0.103428},{"month":10,"riseRate":0,"avgChangeRate":-0.25256},{"month":11,"riseRate":0.4,"avgChangeRate":0.133149},{"month":12,"riseRate":0.8,"avgChangeRate":0.194311}],"exchange":"NASDAQ","name":"Arcutis Biotherapeutics Inc.","nameEN":"Arcutis Biotherapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcutis Biotherapeutics Inc.(ARQT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcutis Biotherapeutics Inc.(ARQT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcutis Biotherapeutics Inc.,ARQT,Arcutis Biotherapeutics Inc.股票,Arcutis Biotherapeutics Inc.股票老虎,Arcutis Biotherapeutics Inc.股票老虎国际,Arcutis Biotherapeutics Inc.行情,Arcutis Biotherapeutics Inc.股票行情,Arcutis Biotherapeutics Inc.股价,Arcutis Biotherapeutics Inc.股市,Arcutis Biotherapeutics Inc.股票价格,Arcutis Biotherapeutics Inc.股票交易,Arcutis Biotherapeutics Inc.股票购买,Arcutis Biotherapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcutis Biotherapeutics Inc.(ARQT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcutis Biotherapeutics Inc.(ARQT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}